Abstract:The binding of drugs to plasma proteins determines its fate within the physiological system, hence profound understanding of its interaction within the bloodstream is important to understand its pharmacodynamics and pharmacokinetics and thereby its therapeutic potential. In this regard, our work delineates the mechanism of interaction of Selumetinib (SEL), a potent anti‐cancer drug showing excellent effect against multiple solid tumors, with plasma protein bovine serum albumin (BSA), using methods such as absorption, steady‐state fluorescence, time‐resolved, fluorescence resonance energy transfer, Fourier transform infrared spectra (FTIR), circular dichroism (CD), synchronous and 3D‐fluorescence, salt fluorescence, molecular docking and molecular dynamic simulations. The BSA fluorescence intensity was quenched with increasing concentration of SEL which indicates interactions of SEL with BSA. Stern–Volmer quenching analysis and lifetime studies indicate the involvement of dynamic quenching. However, some contributions from the static quenching mechanism could not be ruled out unambiguously. The association constant was found to be 5.34 × 105 M−1 and it has a single binding site. The Förster distance (r) indicated probable energy transmission between the BSA and SEL. The positive entropy changes and enthalpy change indicate that the main interacting forces are hydrophobic forces, also evidenced by the results of molecular modeling studies. Conformation change in protein framework was revealed from FTIR, synchronous and 3D fluorescence and CD studies. Competitive binding experiments as well as docking studies suggest that SEL attaches itself to site I (subdomain IIA) of BSA where warfarin binds. Molecular dynamic simulations indicate the stability of the SEL–BSA complex. The association energy between BSA and SEL is affected in the presence of different metals differently.

Synthesis, Anticancer Activity of a Novel Selenadiazole Derivative and Its Interaction with Bovine Serum Albumin

Synthesis of novel genistein amino acid derivatives and investigation on their interactions with bovine serum albumin by spectroscopy and molecular docking

Synthesis of a Novel Hydrazone Derivative and Biophysical Studies of Its Interactions with Bovine Serum Albumin by Spectroscopic, Electrochemical, and Molecular Docking Methods.

el genistein amino acid derivatives and investigation on their interactions with bovine serum albumin by spectroscopy and molecular docking †

Exploring the interaction of a potent anti‐cancer drug Selumetinib with bovine serum albumin: Spectral and computational attributes

Enhancement of Cell Uptake and Antitumor Activity of Selenadiazole Derivatives Through Interaction and Delivery by Serum Albumin

Spectroscopic Studies on the Interaction Between an Anticancer Drug Ampelopsin and Bovine Serum Albumin

Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives and Their Binding Behavior with Bovine Serum Albumin

Spectroscopic Study on the Interaction of Bovine Serum Albumin with Zinc(ii) Phthalocyanine.

Synthesis, Crystal Structure, Anticancer Activity and Interaction with Bovine Serum Albumin of Copper(II) Complex

Mechanistic Interaction Study of Bromo-Noscapine with Bovine Serum Albumin employing Spectroscopic and Chemoinformatics Approaches

A Novel Selenadiazole Derivative Induces Apoptosis in Human Glioma Cells by Dephosphorylation of AKT

Binding Ability of N-(2-Methylene Pyridine) Dehydroabietylamine Schiff Base and Its Copper Complex with Bovine Serum Albumin

Synthesis and in vitro anticancer activities of chiral ruthenium complexes and interaction of the complex with bovine serum albumin

Interaction of Di-2-pyridylketone 2-Pyridine Carboxylic Acid Hydrazone and Its Copper Complex with BSA: Effect on Antitumor Activity As Revealed by Spectroscopic Studies

Synthesis and Biological Activity of Novel Organoselenium Derivatives Targeting Multiple Kinases and Capable of Inhibiting Cancer Progression to Metastases

Uncovering the Molecular and Physiological Processes of Anticancer Leads Binding Human Serum Albumin: A Physical Insight into Drug Efficacy

Synthesis of Meso-5,10,15,20-Tetra [4-(N-pyrrolidinyl)phenyl] Porphyrin and Its Interaction with Bovine Serum Albumin

Insight into the Delivery Channel and Selectivity of Multiple Binding Sites in Bovine Serum Albumin Towards Naphthalimide-Polyamine Derivatives

BSA-binding Properties and Anti-Proliferative Effects of Amino Acids Functionalized Polyoxomolybdates

Synthesis, Biological Evaluation and Mechanism Studies of C-3 Substituted Nitrogenous Heterocyclic 23-Hydroxybetulinic Acid Derivatives As Anticancer Agents